Elimination of CD4lowHLA-G+ T cells overcomes castration-resistance in prostate cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elimination of CD4lowHLA-G+ T cells overcomes castration-resistance in prostate cancer therapy

Published:2018-10-08 Issue:11 Volume:28 Page:1103-1117
ISSN:1001-0602
Container-title:Cell Research
language:en
Short-container-title:Cell Res

Author:

Wang Chao,Chen Jiahuan,Zhang Qianfei,Li Wang,Zhang Shengbo,Xu Yanjie,Wang Fang,Zhang Bing,Zhang Yan,Gao Wei-Qiang

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Ministry of Science and Technology of the People's Republic of China

KC Wong foundation

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41422-018-0089-4.pdf

Reference53 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin. 67, 7–30 (2017).

2. Warde, P. et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial. Lancet 378, 2104–2111 (2011).

3. Widmark, A. et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 373, 301–308 (2009).

4. Watson, P. A., Arora, V. K. & Sawyers, C. L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer 15, 701–711 (2015).

5. Pu, Y. et al. Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse. Sci. Transl. Med. 8, 333ra47–333ra47 (2016).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate cancer;Scientific Reports;2024-06-19

2. Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance;Frontiers in Endocrinology;2024-06-03

3. RISING STARS: Androgens and immune cell function;Journal of Endocrinology;2024-04-03

4. Role of tumor microenvironment in prostate cancer therapy resistance;Therapy Resistance in Prostate Cancer;2024

5. The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer;Cancers;2023-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3